- Indian generics maker Lupin seeds US spinout Kaveri with cash, clinical-phase cancer assetsLupin has spun out two clinical-phase cancer drug candidates to create Kaveri Therapeutics, a U.S.-based startup that plans to raise cash for further development. Kaveri’s programs hit targets purs…Fierce Biotech · 4d ago↗ source
- Roche taps Foundation Medicine’s chief as new North America Diagnostics lead, creates new commercial roleDan Malarek is leaving his role as chief executive of Roche’s sequencing subsidiary Foundation Medicine as he takes up the mantle as President and CEO of Roche Diagnostics North America.Fierce Biotech · 4d ago↗ source
- FDA still focused on lettuce supplier as source of parasite, despite faulty test resultThe FDA said Monday it is still focused on lettuce from Taylor Farms as the source of a multistate outbreak of a diarrhea-causing parasite, despite a faulty test result.